Literature DB >> 9250185

Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team.

W R Bowie1, A S King, D H Werker, J L Isaac-Renton, A Bell, S B Eng, S A Marion.   

Abstract

BACKGROUND: Outbreaks of toxoplasmosis are recognised infrequently. In March, 1995, a sudden increase of serologically diagnosed cases of acute toxoplasmosis was noted in the Greater Victoria area of British Columbia, Canada. Concurrently, but independently, seven cases of acute toxoplasma retinitis were diagnosed against a background of no cases in the previous 5 years.
METHODS: Cases were defined by serological testing, clinical presentation, and residence in Greater Victoria. A screening programme for women who were or had been pregnant was started. Geographical mapping of cases, and case-control studies of symptomatic cases and of women enrolled in the screening programme were done.
FINDINGS: 100 individuals aged 6 to 83 years met the definition for an acute, outbreak-related case. 94 resided in Greater Victoria and six had visited it; 19 had retinitis, 51 had lymphadenopathy, four others had symptoms consistent with toxoplasmosis, seven had other symptoms, 18 were symptom-free, and one would not provide information. 36 (0.9%) of 3812 screened pregnant and postnatal women were cases. Excess cases were not detected outside Greater Victoria and no conventional source of toxoplasmosis was implicated. Mapping studies of cases and of the screened women, and both case-control studies showed significant associations between acute infection and residence in the distribution system of one reservoir supplying water to Greater Victoria (ORs or RRs: 3.53, 3.05, 8.27, and 5.42, respectively). The epidemic curve appeared bimodal, with peaks in December, 1994, and March, 1995, that were preceded by increased rainfall and turbidity in the implicated reservoir.
INTERPRETATION: A municipal water system that uses unfiltered, chloraminated surface water was the likely source of this large community-wide outbreak of toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250185     DOI: 10.1016/s0140-6736(96)11105-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  125 in total

1.  Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana.

Authors:  B Carme; F Bissuel; D Ajzenberg; R Bouyne; C Aznar; M Demar; S Bichat; D Louvel; A M Bourbigot; C Peneau; P Neron; M L Dardé
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Acquired ocular toxoplasmosis in pregnancy.

Authors:  M Ramchandani; J B Weaver; D H M Joynson; P I Murray
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

Review 3.  Toxoplasma gondii: the model apicomplexan.

Authors:  Kami Kim; Louis M Weiss
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

4.  Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages.

Authors:  Chunlei Su; Asis Khan; Peng Zhou; Debashree Majumdar; Daniel Ajzenberg; Marie-Laure Dardé; Xing-Quan Zhu; James W Ajioka; Benjamin M Rosenthal; Jitender P Dubey; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

5.  Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.

Authors:  Christopher P Hencken; Lorraine Jones-Brando; Claudia Bordón; Remo Stohler; Bryan T Mott; Robert Yolken; Gary H Posner; Lauren E Woodard
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

6.  Structural and functional characterization of SporoSAG: a SAG2-related surface antigen from Toxoplasma gondii.

Authors:  Joanna Crawford; Erika Lamb; James Wasmuth; Ognjen Grujic; Michael E Grigg; Martin J Boulanger
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

7.  Determining UV inactivation of Toxoplasma gondii oocysts by using cell culture and a mouse bioassay.

Authors:  Michael W Ware; Swinburne A J Augustine; David O Erisman; Mary Jean See; Larry Wymer; Samuel L Hayes; J P Dubey; Eric N Villegas
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

8.  First report of Toxoplasma gondii sporulated oocysts and Giardia duodenalis in commercial green-lipped mussels (Perna canaliculus) in New Zealand.

Authors:  Alicia Coupe; Laryssa Howe; Elizabeth Burrows; Abigail Sine; Anthony Pita; Niluka Velathanthiri; Emilie Vallée; David Hayman; Karen Shapiro; Wendi D Roe
Journal:  Parasitol Res       Date:  2018-03-17       Impact factor: 2.289

9.  Prevalence of Toxoplasma gondii infection in HIV-infected patients and food animals and direct genotyping of T. gondii isolates, Southern Ghana.

Authors:  Faustina Pappoe; Weisheng Cheng; Lin Wang; Yuanling Li; Dorcas Obiri-Yeboah; Samuel Victor Nuvor; Henock Ambachew; Xiaodong Hu; Qingli Luo; Deyong Chu; Yuanhong Xu; Jilong Shen
Journal:  Parasitol Res       Date:  2017-04-22       Impact factor: 2.289

10.  Evaluation of a strategy for Toxoplasma gondii oocyst detection in water.

Authors:  Isabelle Villena; Dominique Aubert; Philippe Gomis; Hubert Ferté; Jean-Christophe Inglard; Hélène Denis-Bisiaux; Julie-Muriel Dondon; Eric Pisano; Naïma Ortis; Jean-Michel Pinon
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.